Esperion Therapeutics ESPR Unchanged at 313 RangeBound Trading 20260520 Texas TPL Q1 2026 Beat Revenue NA EPS Exceeds by Significant TSSI TSSI Q1 2026 Earnings Call Management Discusses Financial Performance and Strategy Major MA Activity in 2025 A Year of Strategic Consolidation Hassett Claims AI Not Driving Job Losses Yet as Tech Layoffs Persist Global Oil Prices Surge as Iran Conflict Wipes Out Nearly 1 Billion Barrels Private Payrolls Rise 109000 in April Exceeding Expectations ADP Reports